Upton, Committee Schedule Hearing on Deadly Meningitis Outbreak
Michigan leads nation in reported cases
Continuing his committee’s investigation of the deadly meningitis outbreak, U.S. Representative Fred Upton (R- St. Joseph), Chairman of the House Energy and Commerce Committee, today joined other committee leaders in announcing the Subcommittee on Oversight and Investigations will convene a hearing on Wednesday, November 14, 2012. Food and Drug Administration (FDA) Commissioner Margaret Hamburg is scheduled to testify. The subcommittee has also invited James Coffey, Director of the Massachusetts Board of Registration in Pharmacy, and Barry Cadden, Director of Pharmacy and owner of the New England Compounding Center.
Upton, Ranking Member Henry A. Waxman, Subcommittee Chairman Cliff Stearns, and Subcommittee Ranking Member Diana DeGette said, “Our committee has a long, bipartisan history of conducting drug safety oversight. Since the meningitis outbreak, we have been in close contact with the involved agencies and parties, but many unanswered questions remain. The NECC has a history of problems, some of which were documented in an FDA warning letter in 2006 – we want to know what went wrong at this facility, the views and actions of its regulators, and what steps can be taken to ensure such an outbreak never happens again.”